Table 1

Summary of trials of exercise training in patients with chronic heart failure

YearnAgeLVEFPeakV˙o2Study design
Uncontrolled
Sullivan5 19881254.0   (10.0)24.0  (10.0)16.8  (3.8)Open, no control
Minotti6 1990560.0 (9.0)27.0 (7.6)15.5 (4.5)Open, no control
Mancini7 19951455.0 (14.0)22.0 (9.0)13.5 (4.8)Unblinded, uncontrolled, control by drop out
Hornig8 19961147.0 (5.0)21.0 (2.0)17.0 (2.0)Open, control by normals
Magnusson9 19961156.0 (9.0)19.8 (11.3)15.1 (2.9)Open
Controlled
Meyer10 19911263.0 (2.6)23.0 (3.2)13.0 (0.8)Plecebo controlled crossover; lisinopril/placebo with/without training
Coats11 12 19921761.8 (1.5)19.6 (2.3)13.2 (0.9)Controlled crossover
Davey13 19922264 (54–74)22.0 (8.0)14.1 (2.8)Controlled crossover
Koch14 19922555.0 (10.0)26.0 (10.0)18.9 (7.0)Controlled open
Adamopoulos15 19931262.4 (2.6)24.0 (3.4)12.1 (1.2)Controlled crossover
Belardinelli16 19955555.0 (7.0)27.0 (7.0)15.6 (1.3)Controlled
Piepoli17 19961259.6 (1.7)26.4 (1.6)14.6 (1.4)Controlled crossover
  • Values are mean (SD).

  • LVEF, left ventricular ejection fraction; peakV˙o 2, peak oxygen uptake.